Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BTK inhibitors
Biotech
Nurix trims staff as trial for lead BTK degrader kicks off
The company declined to disclose how many employees were affected by the workforce reduction but added that no programs have been cut or paused.
Darren Incorvaia
Nov 21, 2025 5:05am
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor
Nov 10, 2025 6:26am
Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay
Sep 22, 2025 8:00am
Roche links BTK drug to low relapse rate across 96-week MS trial
May 30, 2025 5:19am
Sanofi BTK inhibitor for blood disease raises platelet levels
Nov 5, 2024 1:42pm
Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies
Sep 20, 2024 7:07am